CERE |
Cerevel Therapeutics Holdings, Inc. |
Jul 1, 2024 |
3 |
-942,035 |
4 |
Jul 3, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jun 5, 2024 |
1 |
0 |
4 |
Jun 7, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jun 3, 2024 |
3 |
-1,855,520 |
4 |
Jun 5, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
May 10, 2024 |
3 |
-1,930,125 |
4 |
May 14, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Apr 1, 2024 |
3 |
-1,941,640 |
4 |
Apr 3, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Mar 4, 2024 |
3 |
-1,875,550 |
4 |
Mar 6, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Feb 29, 2024 |
3 |
-1,882,890 |
4 |
Mar 4, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Feb 6, 2024 |
3 |
-104,110 |
4 |
Feb 8, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jan 2, 2024 |
3 |
-1,936,815 |
4 |
Jan 4, 2024 |
Director |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Jan 2, 2024 |
2 |
0 |
4 |
Jan 4, 2024 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Nov 14, 2023 |
3 |
-493,571 |
4 |
Nov 16, 2023 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Nov 7, 2023 |
6 |
-584,955 |
4 |
Nov 9, 2023 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Nov 2, 2023 |
6 |
-2,183,697 |
4 |
Nov 6, 2023 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Sep 7, 2023 |
3 |
-1,028,415 |
4 |
Sep 8, 2023 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jul 11, 2023 |
3 |
-1,326,340 |
4 |
Jul 13, 2023 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jun 1, 2023 |
3 |
-1,455,070 |
4 |
Jun 5, 2023 |
CEO and Chairperson, Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
May 4, 2023 |
5 |
-1,398,434 |
4 |
May 8, 2023 |
CEO and Chairperson, Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Apr 11, 2023 |
3 |
-1,078,130 |
4 |
Apr 13, 2023 |
CEO and Chairperson, Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Mar 2, 2023 |
6 |
-1,180,947 |
4 |
Mar 6, 2023 |
CEO and Chairperson, Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Feb 6, 2023 |
6 |
-1,481,401 |
4 |
Feb 8, 2023 |
CEO and Chairperson, Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Jan 5, 2023 |
4 |
-1,321,871 |
4 |
Jan 6, 2023 |
CEO and Chairperson, Director |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Jan 3, 2023 |
2 |
0 |
4 |
Jan 5, 2023 |
Director |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Dec 28, 2022 |
12 |
-1,565,412 |
4 |
Dec 30, 2022 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Dec 9, 2022 |
4 |
-1,158,300 |
4 |
Dec 13, 2022 |
CEO and Chairperson, Director |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Sep 6, 2022 |
13 |
-1,253,229 |
4 |
Sep 8, 2022 |
Director |
CERE |
Cerevel Therapeutics Holdings, Inc. |
Feb 9, 2022 |
1 |
0 |
4 |
Feb 11, 2022 |
CEO and Chairperson, Director |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Jan 3, 2022 |
2 |
0 |
4 |
Jan 5, 2022 |
Director |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Sep 15, 2021 |
17 |
-3,500,677 |
4 |
Sep 17, 2021 |
Director |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Aug 17, 2021 |
6 |
-1,827,180 |
4 |
Aug 19, 2021 |
Director |
REGN |
REGENERON PHARMACEUTICALS, INC. |
Aug 13, 2021 |
3 |
-559,060 |
4 |
Aug 16, 2021 |
Director |